Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study. Pasternak B, Wintzell V, Hviid A, Eliasson B, et al. BMJ 2024;385:e078225.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pasternak B, Wintzell V, Hviid A, Eliasson B, et al. Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study. BMJ 2024;385:e078225.
PMID: 38683947